These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28424702)

  • 1. Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance.
    Yamada A; Arakaki R; Saito M; Kudo Y; Ishimaru N
    Front Immunol; 2017; 8():403. PubMed ID: 28424702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
    Nakano K; Saito K; Mine S; Matsushita S; Tanaka Y
    Apoptosis; 2007 Jan; 12(1):45-54. PubMed ID: 17136494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual role of TGF-β1 on Fas-induced apoptosis in lung epithelial cells.
    Bai L; Yu Z; Wang C; Qian G; Wang G
    Respir Physiol Neurobiol; 2011 Aug; 177(3):241-6. PubMed ID: 21539941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces.
    Guller S; LaChapelle L
    Semin Reprod Endocrinol; 1999; 17(1):39-44. PubMed ID: 10406074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
    Aruna BV; Ben-David H; Sela M; Mozes E
    Immunology; 2006 Jul; 118(3):413-24. PubMed ID: 16827902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis.
    Volpe E; Sambucci M; Battistini L; Borsellino G
    Front Immunol; 2016; 7():382. PubMed ID: 27729910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
    Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
    J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer B lymphocytes and their fas ligand positive exosomes as inducers of immune tolerance.
    Lundy SK; Klinker MW; Fox DA
    Front Immunol; 2015; 6():122. PubMed ID: 25852690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.
    Famularo G; Nucera E; Marcellini S; De Simone C
    Med Hypotheses; 1999 Jul; 53(1):50-62. PubMed ID: 10499826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
    Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
    J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
    Kauma SW; Huff TF; Hayes N; Nilkaeo A
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.
    O'Reilly LA; Hughes P; Lin A; Waring P; Siebenlist U; Jain R; Gray DH; Gerondakis S; Strasser A
    Cell Death Differ; 2015 May; 22(5):767-78. PubMed ID: 25361085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover.
    French LE; Tschopp J
    Behring Inst Mitt; 1996 Oct; (97):156-60. PubMed ID: 8950473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function.
    Cui H; Sherr DH; el-Khatib M; Matsui K; Panka DJ; Marshak-Rothstein A; Ju ST
    Cell Immunol; 1996 Feb; 167(2):276-84. PubMed ID: 8603437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.
    Ivanov VN; Hei TK
    Exp Cell Res; 2006 May; 312(8):1401-17. PubMed ID: 16487513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.